Page last updated: 2024-08-17

spironolactone and osilodrostat

spironolactone has been researched along with osilodrostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bral, JM; Hartman, D; Karns, AD; Peppard, T; Schumacher, C	1
Beil, M; Chen, W; Dole, WP; Fu, F; Hu, CW; Jeng, AY; LaSala, D; Leung-Chu, J; Liang, G; Liu, J; Ménard, J; Rebello, S; Rigel, DF; Watson, C; Zhang, Y	1

Trials

2 trial(s) available for spironolactone and osilodrostat

Article	Year
Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension. Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cytochrome P-450 CYP11B2; Double-Blind Method; Eplerenone; Female; Humans; Hypertension; Iceland; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prospective Studies; Pyridines; Spironolactone; Treatment Outcome; United States; Young Adult	2013
Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects. Journal of translational medicine, 2014, Dec-10, Volume: 12 Topics: Angiotensinogen; Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Double-Blind Method; Eplerenone; Haplorhini; Heart; Humans; Imidazoles; Kidney; Male; Placebos; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Spironolactone; Translational Research, Biomedical	2014

Article

Year

Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:3

Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cytochrome P-450 CYP11B2; Double-Blind Method; Eplerenone; Female; Humans; Hypertension; Iceland; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prospective Studies; Pyridines; Spironolactone; Treatment Outcome; United States; Young Adult

2013

Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects.

Journal of translational medicine, 2014, Dec-10, Volume: 12

Topics: Angiotensinogen; Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Double-Blind Method; Eplerenone; Haplorhini; Heart; Humans; Imidazoles; Kidney; Male; Placebos; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Spironolactone; Translational Research, Biomedical

2014